Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects (Q34056269)

30 July 2017

Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects (English)

1 reference

human subject research project

30 July 2017

0 references

1 reference

1 reference

1 reference

11

Robert J Linhardt

1 reference

30 July 2017

Shaker A Mousa

1

1 reference

30 July 2017

Fuming Zhang

2

1 reference

30 July 2017

Ahmad Aljada

3

1 reference

30 July 2017

Seema Chaturvedi

4

1 reference

30 July 2017

Majde Takieddin

5

1 reference

30 July 2017

Haifeng Zhang

6

1 reference

30 July 2017

Lianli Chi

7

1 reference

30 July 2017

M Cristina Castelli

8

1 reference

30 July 2017

Kristen Friedman

9

1 reference

30 July 2017

Michael M Goldberg

10

1 reference

30 July 2017

1 December 2007

1 reference

The Journal of Clinical Pharmacology

30 July 2017

1 reference

30 July 2017

47

1 reference

30 July 2017

1508-1520

1 reference

30 July 2017

12

1 reference

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

The anticoagulant activation of antithrombin by heparin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Heparins--anionic polyelectrolyte drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Effects of acidity, cations and alcoholic fractionation on absorption of heparin from gastrointestinal tract

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4135515

Oral administration of liposomally-entrapped heparin to beagle dogs

28 October 2018

1 reference

12 December 2020

Olive oil-provoked bile-dependent absorption of heparin from gastro-intestinal tract in rats

1 reference

12 December 2020

New heparin complexes active by intestinal absorption: I-multiple ion pairs with basic organic compounds

1 reference

12 December 2020

Liposomes from soya phospholipids as percutaneous drug carriers. 2nd communication: quantitative in vivo investigations with radioactively labelled liposomes

1 reference

12 December 2020

Non-anticoagulant uses of heparin

1 reference

12 December 2020

Establishing a therapeutic range for heparin therapy

1 reference

12 December 2020

N-acylated alpha-amino acids as novel oral delivery agents for proteins

1 reference

12 December 2020

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

12 December 2020

Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group

1 reference

12 December 2020

4-[4-[(2-Hydroxybenzoyl)amino]phenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone

1 reference

12 December 2020

Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers

1 reference

12 December 2020

Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations

1 reference

12 December 2020

Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans

1 reference

12 December 2020

A modified uronic acid carbazole reaction

1 reference

12 December 2020

Enhancement of jejunal absorption of heparinoid by sodium ethylenediaminetetraacetate in the dog

1 reference

12 December 2020

Identifiers

DOI

10.1177/0091270007307242

1 reference

30 July 2017

1 reference

30 July 2017

1 reference